METHOD FOR TREATMENT OF GLAUCOMA OPTICAL NEUROPATHY Russian patent published in 2006 - IPC A61K38/47 A61K31/15 A61K31/167 A61K31/4412 A61K38/30 A61K38/08 A61P27/02 A61M1/36 

FIELD: medicine, ophthalmology.

SUBSTANCE: method involves carrying out the lymphotropic therapy by submastoidal (parotid) blockades including course of 6-8 procedures every day by using the following medicinal mixture comprising, mg: lidocaine, 50-100; cortexin, 10-20; dalargin, 0.001-0.002; mexidol, 50-100; lydazum, 16-32 U, and additional 3-4 procedures of discrete plasmapheresis with interval for 48-72 h; exfusion value for a single procedure is 20-25% of volume of circulating plasma, not above. The separated cellular mass is activated by incubation with 300-500 mg of preparation mildronate in thermostat at temperature 36.6-37.0°C for 30-40 min followed by reinfusion into the general blood stream. Method provides elimination of the cause in progressing the glaucoma optical neuropathy based on high region exposition and concentration of medicinal preparations on background of detoxifying, hemorheological and immunotropic effect of plasmapheresis.

EFFECT: improved method of treatment.

2 cl, 2 ex